SBIR grant

The firm plans to integrate its technology with a compatible microfluidic sample prep method developed by researchers at Columbia University.

SolveBio is continuing development of a cloud-based genetic variation analysis and visualization system called Variant Explorer.

The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.

The company aims to commercialize the platform and related services by late 2018.

The SBIR Phase 1 award will go toward developing a test using immuno-PCR technology to detect toxins in medical marijuana. 

The company is working with the University of Florida Health Cancer Center to validate its RadTox QuantiDNA test as a monitor of cfDNA in patient plasma.

The company has received grant funding for diagnostic development projects, and is also seeking its first pharma service customers to provide nearer-term revenue.

The funding will go towards developing the PathMap companion diagnostic technology, based on the firm's SnapPath platform. 

Proposed increases to small business programs touch off fight between business and research groups, ScienceInsider reports.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.